{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:32:24Z","timestamp":1794335544441,"version":"4.9.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Psoriasis is a chronic, relapsing, inflammatory skin disease and has been increasing year by year. It is linked to other serious illnesses, such as psoriatic arthritis, cardiometabolic syndrome, and depression, resulting in a notable decrease in the quality of life for patients. Existing therapies merely alleviate symptoms, rather than providing a cure. An in-depth under-standing of the pathogenesis of psoriasis is helpful to discover new therapeutic targets and develop effective novel therapeutic agents, so it has important clinical significance. This article reviews the new progress in the study of pathogenesis and natural products of psoriasis in recent years. These natural products were summarized, mainly classified as terpenoids, polyphenols and alkaloids. However, the translation of experimental results to the clinic takes a long way to go.<\/jats:p>","DOI":"10.3389\/fmed.2024.1386783","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:27:08Z","timestamp":1725427628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Promising strategies in natural products treatments of psoriasis-update"],"prefix":"10.3389","volume":"11","author":[{"given":"Sihua","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/09546634.2018.1528330","article-title":"Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management","volume":"30","author":"Pithadia","year":"2019","journal-title":"J Dermatol Treat"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/PTT.S169389","article-title":"The impact of genital psoriasis on quality of life: a systematic review","volume":"8","author":"Yang","year":"2018","journal-title":"Psoriasis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1468-3083.2012.04531.x","article-title":"Psoriasis prevalence among the 2009 AAD National Mela-Noma\/skin Cancer screening program participants","volume":"27","author":"Lima","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","article-title":"Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation","volume":"25","author":"Kastelein","year":"2007","journal-title":"Ann Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3390\/molecules27061953","article-title":"Relationship between immune cells, depression, stress, and psoriasis: could the use of natural products be helpful?","volume":"27","author":"Alesci","year":"2022","journal-title":"Molecules"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.4028\/www.scientific.net\/AMM.638-640.1391","article-title":"Progress on research of miRNAs in psoriasis","author":"Zhan","year":"2014","journal-title":"J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"CD011535","DOI":"10.1002\/14651858.CD011535.pub2","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"12","author":"Sbidian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ijms19010179","article-title":"Scanning the Immunopathogenesis of psoriasis","volume":"19","author":"Chiricozzi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.3390\/ijms21207488","article-title":"New treatment addressing the pathogenesis of psoriasis","volume":"21","author":"Michio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref14","first-page":"179","article-title":"Evaluating serum levels of IL-33, IL-36, IL-37 and gene expression of IL-37 in patients with psoriasis vulgaris","volume":"17","author":"Sehat","year":"2018","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/ijmm.2021.4951","article-title":"An update on genetic basis of generalized pustular psoriasis","volume":"47","author":"Zhou","year":"2021","journal-title":"Int J Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.3390\/ijms22094344","article-title":"Exploring the role of IL-36 cytokines as a new target in psoriatic disease","volume":"22","author":"Helena","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e201900586","DOI":"10.26508\/lsa.201900586","article-title":"Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice","volume":"3","author":"Hernandez-Santana","year":"2020","journal-title":"Life Sci Alliance"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.3390\/ijms22179294","article-title":"The role of epigenetic factors in psoriasis","volume":"22","author":"Klaudia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdermsci.2010.07.011","article-title":"Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris","volume":"60","author":"Zhang","year":"2010","journal-title":"J Dermatol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00403-019-02005-9","article-title":"DNA methylation and inflammatory skin diseases","volume":"312","author":"Mervis","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13148-018-0541-9","article-title":"Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis","volume":"10","author":"Chandra","year":"2018","journal-title":"Clin Epigenetics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2012.04.128","article-title":"The characteristics of genome-wide DNA methylation in na\u00efve CD4+ T cells of pa-tients with psoriasis or atopic dermatitis","volume":"422","author":"Han","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00403-013-1432-8","article-title":"DNA methylation analysis of CD4+ T cells in patients with psoriasis","volume":"306","author":"Park","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/exd.14332","article-title":"Dysregulated epigenetic modifications in psoriasis","volume":"30","author":"Chang","year":"2021","journal-title":"Exp Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1684\/ejd.2011.1383","article-title":"Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris","volume":"21","author":"Zhang","year":"2011","journal-title":"Eur J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/exd.14334","article-title":"Epigenetic-modifying therapies: an emerging avenue for the treatment of inflammatory skin diseases","volume":"30","author":"Yi","year":"2021","journal-title":"Exp Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/ijms21072356","article-title":"Histone deacetylation inhibitors as modulators of regulatory T cells","volume":"21","author":"von Knethen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/jid.2015.82","article-title":"SIRT1 activation ameliorates aldara-induced psoriasiform phenotype and histology in mice","volume":"135","author":"Xie","year":"2015","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0142081","DOI":"10.1371\/journal.pone.0142081","article-title":"A randomized, placebo-controlled study of SRT2104, a SIRT1 acti-vator, in patients with moderate to severe psoriasis","volume":"10","author":"Krueger","year":"2015","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/biom12081072","article-title":"Anti-inflammatory microRNAs for treating inflammatory skin diseases","volume":"12","author":"Yang","year":"2022","journal-title":"Biomol Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e14221","DOI":"10.1111\/dth.14221","article-title":"Insightful exploring of microRNAs in psoriasis and its targeted topical delivery","volume":"33","author":"Pradyuth","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/biomedicines10081934","article-title":"Contribution of the environment, epigenetic mechanisms and non-coding RNAs in psoriasis","volume":"10","author":"Antonatos","year":"2022","journal-title":"Biomedicines"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1081\/IPH-120037712","article-title":"Dehy-drocostus lactone enhances tumor necrosis factor-alpha-induced apoptosis of human leukemia HL-60 cells","volume":"26","author":"Oh","year":"2004","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/acn3.54","article-title":"(\u2212)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways","volume":"1","author":"Chang","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.intimp.2018.12.021","article-title":"Thymol as a reciprocal regulator of T cell differentiation: pro-motion of regulatory T cells and suppression of Th1\/ Th17 cells","volume":"67","author":"Namdari","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"ref36","volume-title":"Study on the mechanism of rosin in the treatment of psoriatic dermatitis and related substances","author":"Li","year":"2020"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"113934","DOI":"10.1016\/j.jep.2021.113934","article-title":"Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice","volume":"272","author":"Li","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.intimp.2019.05.030","article-title":"Betulinic acid suppresses Th17 response and ameliorates psoriasis-like murine skin inflammation","volume":"73","author":"Liu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2015.12.040","article-title":"Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion","volume":"772","author":"Zhao","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.intimp.2014.12.032","article-title":"Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation","volume":"24","author":"Sun","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdermsci.2014.03.004","article-title":"Resveratrol inhibition of human keratinocyte proliferation via SIRT1\/ARNT\/ERK dependent downregulation of aquaporin 3","volume":"75","author":"Wu","year":"2014","journal-title":"J Dermatol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/sj.jid.5700801","article-title":"Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light","volume":"127","author":"Dujic","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e0138754","DOI":"10.1371\/journal.pone.0138754","article-title":"Red light combined with blue light irradiation regulates proliferation and apoptosis in skin keratinocytes in combination with low concentrations of curcumin","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/138920010791526097","article-title":"Rottlerin: bases for a possible usage in psoriasis","volume":"11","author":"Maioli","year":"2010","journal-title":"Curr Drug Metab"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e0190051","DOI":"10.1371\/journal.pone.0190051","article-title":"Rottlerin as a ther-apeutic approach in psoriasis: evidence from in vitro and in vivo studies","volume":"12","author":"Min","year":"2017","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejmech.2015.02.003","article-title":"Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents","volume":"93","author":"Zhang","year":"2015","journal-title":"Eur J Med Chem"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e0205340","DOI":"10.1371\/journal.pone.0205340","article-title":"The small molecule rhodomyrtone suppresses TNF-\u03b1 and IL-17A-induced keratinocyte inflammatory responses: a potential new therapeutic for psoriasis","volume":"13","author":"Chorachoo","year":"2018","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejphar.2013.05.041","article-title":"Rhododendrin ameliorates skin inflammation through inhibition of NF-\u03baB, MAPK, and PI3K\/Akt signaling","volume":"714","author":"Jeon","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e14230","DOI":"10.1111\/jfbc.14230","article-title":"Baicalein: a review on its anti-cancer effects and mechanisms in lung carcinoma","volume":"46","author":"Chandrashekar","year":"2022","journal-title":"J Food Biochem"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/exd.12140","article-title":"Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models","volume":"22","author":"Chamcheu","year":"2013","journal-title":"Exp Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/bjd.13513","article-title":"Topical application of del-phinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and in-hibiting inflammation","volume":"172","author":"Pal","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-015-2641-6","article-title":"Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-\u03baB-mediated inflammation and keratinocyte proliferation","volume":"413","author":"An","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.13363","article-title":"Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model","volume":"198","author":"Liu","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"106070","DOI":"10.1016\/j.intimp.2019.106070","article-title":"Effects of luteolin on treatment of psoriasis by repressing HSP90","volume":"79","author":"Lv","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"109747","DOI":"10.1016\/j.biopha.2019.109747","article-title":"Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2\/STAT3 signal pathways","volume":"123","author":"Yuan","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e0192297","DOI":"10.1371\/journal.pone.0192297","article-title":"Molecular action of isoflavone genistein in the human epithelial cell line HaCaT","volume":"13","author":"Smoli\u0144ska","year":"2018","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12906-019-2535-3","article-title":"Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis","volume":"19","author":"Deenonpoe","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijpharm.2014.06.010","article-title":"Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles","volume":"472","author":"Paleco","year":"2014","journal-title":"Int J Pharm"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"Di","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.intimp.2018.04.018","article-title":"Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"59","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lfs.2019.01.019","article-title":"Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1\/ERK1\/2 pathway","volume":"219","author":"Li","year":"2019","journal-title":"Life Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"106767","DOI":"10.1016\/j.intimp.2020.106767","article-title":"Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1\/Th17 cell population and keratinocyte activation","volume":"87","author":"Kim","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41419-019-1510-8","article-title":"Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: immunological functions and potential biomarkers","volume":"26","author":"Liu","year":"2017","journal-title":"Exp Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"225re1","DOI":"10.1126\/scitranslmed.3008089","article-title":"Targeting miR-21 to treat psoriasis","volume":"6","author":"Guinea-Viniegra","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.1202695","article-title":"MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cy-tokine and chemokine production in keratinocytes via targeting serine\/threonine kinase40","volume":"190","author":"Xu","year":"2013","journal-title":"J Immunol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin Immunol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte prolif-eration by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e12698","DOI":"10.1111\/cpr.12698","article-title":"Long non-coding RNAs in cutaneous biology and proliferative skin diseases: ad-vances and perspectives","volume":"53","author":"Tang","year":"2020","journal-title":"Cell Prolif"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nsmb.2480","article-title":"Structure and function of long noncoding RNAs in epigenetic regulation","volume":"20","author":"Mercer","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13059-014-0570-4","article-title":"Analysis of long non-coding RNAs highlights tissue-specific expression pat-terns and epigenetic profiles in normal and psoriatic skin","volume":"16","author":"Tsoi","year":"2015","journal-title":"Genome Biol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.3892\/mmr.2019.9993","article-title":"Long noncoding RNA expression profile and functional analysis in psoriasis","volume":"19","author":"Yan","year":"2019","journal-title":"Mol Med Rep"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12703\/P6-4","article-title":"Advances in treating psoriasis","volume":"6","author":"Belge","year":"2014","journal-title":"F1000Prime Rep"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/pharmaceutics13071064","article-title":"Therapeutic development based on the immunopathogenic mechanisms of psoriasis","volume":"13","author":"Tseng","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J Biol Chem"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal in-flammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00403-017-1792-6","article-title":"Expression of janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study","volume":"310","author":"Nada","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3 centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.14018","article-title":"Tofacitinib, an oral janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials","volume":"173","author":"Papp","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.3390\/cells10123559","article-title":"Role of aryl hydrocarbon receptor activation in inflammatory chronic skin diseases","volume":"10","author":"Napolitano","year":"2021","journal-title":"Cells"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.3390\/ijms20215424","article-title":"Aryl hydrocarbon receptor in atopic dermatitis and psoriasis","volume":"20","author":"Furue","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/pr.113.007823","article-title":"Aryl hydrocarbon receptor control of adaptive immunity","volume":"65","author":"Quintana","year":"2013","journal-title":"Pharmacol Rev"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/exd.12350","article-title":"Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases","volume":"23","author":"Kim","year":"2014","journal-title":"Exp Dermatol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2014.04.019","article-title":"Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions","volume":"40","author":"Di Meglio","year":"2014","journal-title":"Immunity"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/ijms19061654","article-title":"Upregulation of FLG, LOR, and IVL expression by rhodiola crenulata root extract via aryl hydrocarbon receptor: differential involvement of OVOL1","volume":"19","author":"Hashimoto-Hachiya","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18091948","article-title":"Antioxidant artemisia princeps extract enhances the expression of filaggrin and loricrin via the AHR\/OVOL1 pathway","volume":"18","author":"Hirano","year":"1948","journal-title":"Int J Mol Sci"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2103629","article-title":"Phase 3 trials of Tapinarof cream for plaque psoriasis","volume":"385","author":"Lebwohl","year":"2021","journal-title":"N Engl J Med"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"12017","DOI":"10.1038\/srep12017","article-title":"Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-\u03b1 treatment","volume":"5","author":"Nada","year":"2015","journal-title":"Sci Rep"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.4049\/jimmunol.178.9.5425","article-title":"Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate","volume":"178","author":"Liao","year":"2007","journal-title":"J Immunol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1194\/jlr.RA119000254","article-title":"Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differen-tiation and attenuates psoriasis in mice","volume":"61","author":"Jeon","year":"2020","journal-title":"J Lipid Res"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12944-023-01813-3","article-title":"Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target","volume":"22","author":"Zhao","year":"2023","journal-title":"Lipids Health Dis"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.jid.5701207","article-title":"Lysophospholipid receptor-mediated calcium signaling in human keratinocytes","volume":"128","author":"Lichte","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0898-6568(03)00114-1","article-title":"Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt\/protein kinase B inactivation","volume":"16","author":"Kim","year":"2004","journal-title":"Cell Signal"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdermsci.2013.03.006","article-title":"Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis","volume":"71","author":"Schaper","year":"2013","journal-title":"J Dermatol Sci"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jdv.17764","article-title":"Novel functions of S1P in chronic itchy and inflammatory skin diseases","volume":"36","author":"Gray","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","article-title":"Metabolic pathways that control skin homeostasis and inflam-mation","volume":"26","author":"Cibrian","year":"2020","journal-title":"Trends Mol Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41591-018-0003-0","article-title":"Differential glucose requirement in skin homeostasis and injury identifies a thera-peutic target for psoriasis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"765790","DOI":"10.3389\/fphar.2021.765790","article-title":"Pyruvate kinase M2 mediates glycolysis contributes to psoriasis by promoting keratinocyte proliferation","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.immuni.2020.06.004","article-title":"Excessive polyamine generation in keratinocytes promotes self-RNA sensing by den-dritic cells in psoriasis","volume":"53","author":"Lou","year":"2020","journal-title":"Immunity"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","article-title":"Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation","volume":"145","author":"Cibrian","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/ijms23010121","article-title":"Expression patterns of clock gene mRNAs and clock proteins in human psoriatic skin samples","volume":"23","author":"Nemeth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/ijms18112297","article-title":"Old and new biological therapies for psoriasis","volume":"18","author":"Ronholt","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1517\/13543784.2015.1076793","article-title":"An overview of developing TNF-\u03b1 targeted therapy for the treatment of psoriasis","volume":"24","author":"Campa","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.3892\/etm.2018.6859","article-title":"Efficacy of several biological therapies for treating moderate to severe psoriasis: a network meta-analysis","volume":"16","author":"Geng","year":"2018","journal-title":"Exp Ther Med"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"CD011535","DOI":"10.1002\/14651858.CD011535.pub5","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"5","author":"Sbidian","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms20102558","article-title":"Apoptotic or Antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis","volume":"20","author":"Huang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1080\/14786419.2021.2020265","article-title":"Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity","volume":"36","author":"Fumia","year":"2021","journal-title":"Nat Prod Res"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/07315724.2021.1965503","article-title":"Immunostimulant and antidepressant effect of natural compounds in the management of COVID-19 symptoms","volume":"41","author":"Alesci","year":"2021","journal-title":"J Am Coll Nutr"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2174\/0929867323666160321121819","article-title":"Anti-psoriasis agents from natural plant sources","volume":"23","author":"Bonesi","year":"2016","journal-title":"Curr Med Chem"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1080\/14786419.2020.1830396","article-title":"Biological effect of astaxanthin on alcohol-induced gut damage in Carassius auratus used as experimental model","volume":"35","author":"Alessio","year":"2020","journal-title":"Nat Prod Res"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/14786419.2014.979417","article-title":"Production, and extraction of astaxanthin from Phaffia rhodozyma and its biological effect on alcohol-induced renal hypoxia in Carassius auratus","volume":"29","author":"Alesci","year":"2015","journal-title":"Nat Prod Res"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/10_2014_295","article-title":"Biosynthesis and biological functions of Terpenoids in plants","volume-title":"Bio-technology of isoprenoids","author":"Tholl","year":"2015"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/ijd.12607","article-title":"Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review","volume":"53","author":"Zhang","year":"2014","journal-title":"Int J Dermatol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e107904","DOI":"10.1371\/journal.pone.0107904","article-title":"Inhibition of inflam-matory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydro-costuslactone and costunolide","volume":"9","author":"Scarponi","year":"2014","journal-title":"PLoS One"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"e20174","DOI":"10.1371\/journal.pone.0020174","article-title":"Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation","volume":"6","author":"Butturini","year":"2011","journal-title":"PLoS One"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1080\/14786419.2015.1010084","article-title":"Study of quantitative and qualitative variations in essential oils of Sicilian Rosmarinus officinalis L","volume":"29","author":"Tuttolomondo","year":"2015","journal-title":"Nat Prod Res"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"153669","DOI":"10.1016\/j.phymed.2021.153669","article-title":"Paeoniflorin: a neuroprotective monoterpenoid glycoside with promising anti-depressive properties","volume":"90","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drudis.2019.11.001","article-title":"Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems","volume":"25","author":"Khursheed","year":"2020","journal-title":"Drug Discov Today"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","article-title":"The therapeutic potential of curcumin: a review of clinical trials","volume":"163","author":"Salehi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00280-010-1470-2","article-title":"A phase I\/II study of gemcitabine-based chemotherapy plus curcumin for patients with gem-citabine-resistant pancreatic Cancer","volume":"68","author":"Kanai","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3889\/oamjms.2018.055","article-title":"Use of curcumin in psoriasis","volume":"6","author":"Nardo","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.lfs.2007.12.020","article-title":"Rottlerin inhibits the nuclear factor \u03baB\/cyclin-D1 cascade in MCF-7 breast cancer cells","volume":"82","author":"Torricelli","year":"2008","journal-title":"Life Sci"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2015.12.005","article-title":"Rhodomyrtone as a potential anti-proliferative and apoptosis inducing agent in HaCaT keratinocyte cells","volume":"772","author":"Chorachoo","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ptr.6006","article-title":"Psoralea corylifolia L: ethnobotanical, biological, and chemical as-pects:a review","volume":"32","author":"Alam","year":"2018","journal-title":"Phytother Res"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000368445","article-title":"Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis","volume":"28","author":"Chamcheu","year":"2015","journal-title":"Skin Pharmacol Physiol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"e90739","DOI":"10.1371\/journal.pone.0090739","article-title":"Luteolin inhibits human keratinocyte activation and decreases NF-\u03baB induction that is increased in psoriatic skin","volume":"9","author":"Weng","year":"2014","journal-title":"PLoS One"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ptr.3084","article-title":"Effect of taxifolin glycoside on atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"24","author":"Ahn","year":"2010","journal-title":"Phytother Res"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.intimp.2019.01.054","article-title":"Genistein suppresses psoria-sis-related inflammation through a STAT3-NF-\u03baB-dependent mechanism in keratinocytes","volume":"69","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.3390\/molecules28155623","article-title":"Phytochemical properties, extraction, and pharmacological benefits of Naringin: a review","volume":"28","author":"Shilpa","year":"2023","journal-title":"Molecules"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ptr.7397","article-title":"Chemistry, pharmacokinetics, pharmacological activities, and toxicity of Quercitrin","volume":"36","author":"Chen","year":"2022","journal-title":"Phytother Res"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","article-title":"Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway","volume":"48","author":"Chen","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"768708","DOI":"10.3389\/fphar.2021.768708","article-title":"Insights into Amentoflavone: a natural Mul-tifunctional Biflavonoid","volume":"12","author":"Xiong","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/jcmm.17184","article-title":"Topical astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice via suppression dendritic cell-Th17 inflammation axis","volume":"26","author":"Xu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2014.10.009","article-title":"An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17","volume":"26","author":"Grine","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol Clin"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/jid.2013.404","article-title":"IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions","volume":"134","author":"Croxford","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1186\/s12885-015-1706-y","article-title":"Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Cancer"},{"key":"ref142","first-page":"319","article-title":"A review of indigo Naturalis as an alternative treatment for nail psoriasis","volume":"15","author":"McDermott","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e0142634","DOI":"10.1371\/journal.pone.0142634","article-title":"Indirubin increases CD4+CD25+Foxp3+ regulatory T cells to prevent immune thrombocytopenia in mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bjd.15894","article-title":"Comparison of indirubin concentrations in indigo naturalis oint-ment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial","volume":"178","author":"Lin","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.molimm.2018.07.011","article-title":"Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing \u03b3\u03b4 T cells","volume":"101","author":"Xie","year":"2018","journal-title":"Mol Immunol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"BSR20180958","DOI":"10.1042\/BSR20180958","article-title":"Indirubin attenuates mouse psoriasis-like skin lesion in a CD274-dependent manner: an achievement of RNA sequencing","volume":"38","author":"Xue","year":"2018","journal-title":"Biosci Rep"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1033498","DOI":"10.3389\/fimmu.2022.1033498","article-title":"Indirubin combined with umbilical cord mesenchymal stem cells to relieve psoriasis-like skin lesions in BALB\/c mice","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"key":"ref148","first-page":"21","article-title":"Efcacy of Yinxieling ointment on 675 cases","volume":"11","author":"Min","year":"1990","journal-title":"Chin Tradit Patent Med"},{"key":"ref149","first-page":"442","article-title":"Clinical study on Huoxuesanyu xiaoyin decoction for treating psoriasis vulgaris with blood stasis syndrome","volume":"5","author":"Shi","year":"2005","journal-title":"J Chin Med Mater"},{"key":"ref150","first-page":"65","article-title":"Clinical research on JiaWeiHuangLianJieD decoction for treatment of psoriasis vulgaris","volume":"4","author":"Wei","year":"2010","journal-title":"Chin J Inf Tradit Chin Med"},{"key":"ref151","first-page":"125","article-title":"Clinical research on Tuiyintang combined with NB-UVB for psoriasis vulgaris","volume":"1","author":"Baohua","year":"2014","journal-title":"LiShizhen Med Mater Med Res"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/542025a","article-title":"Consider drug efficacy before first-in-human trials","volume":"542","author":"Kimmelman","year":"2017","journal-title":"Nature"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1386783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:27:17Z","timestamp":1725427637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1386783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":153,"alternative-id":["10.3389\/fmed.2024.1386783"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1386783","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"article-number":"1386783"}}